scispace - formally typeset
Y

Yasuhiro Komatsu

Researcher at Mount Sinai St. Luke's and Mount Sinai Roosevelt

Publications -  33
Citations -  1352

Yasuhiro Komatsu is an academic researcher from Mount Sinai St. Luke's and Mount Sinai Roosevelt. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 15, co-authored 33 publications receiving 1104 citations. Previous affiliations of Yasuhiro Komatsu include University of Tsukuba & Jikei University School of Medicine.

Papers
More filters
Journal ArticleDOI

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease

TL;DR: The Japanese Society for Dialysis Therapy guideline committee, chaired by Dr Y. Tsubakihara, presents the Japanese guidelines, which replace the “2004 JSDT Guidelines for Renal Anemia in Chronic Hemodialysis Patients,” and contain new, additional guidelines for peritoneal dialysis, non‐dialysis (ND), and pediatric chronic kidney disease (CKD) patients.
Journal ArticleDOI

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

TL;DR: Compared to placebo, febuxostat did not mitigate the decline in kidney function among patients with stage 3 CKD and asymptomatic hyperuricemia andSubgroup analysis demonstrated a significant benefit from febUXostat in patients without proteinuria and for whom serum creatinine concentration was lower than the median.
Journal ArticleDOI

Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children.

TL;DR: Plasmapheresis appears to be effective for the prevention and treatment of posttransplant recurrence of FSGS, although further consideration of cost/benefit and risks is required before a conclusive judgement can be made.
Journal ArticleDOI

Longitudinal Study of the Decline in Renal Function in Healthy Subjects

TL;DR: The reference values for the rate of eGFR decline stratified by gender, age, and renal stage in healthy subjects were clarified for the first time and depended mainly on baseline eG FR, but not on age, with a slower decline with a lower baseline e GFR.